Zensar Technologies is currently trading at Rs. 191.00, up by 6.35 points or 3.44% from its previous closing of Rs. 184.65 on the BSE.
The scrip opened at Rs. 185.20 and has touched a high and low of Rs. 191.00 and Rs. 185.20 respectively. So far 4,506 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 204.95 on 17-Feb-2012 and a 52 week low of Rs. 113.15 on 21-Nov-2011.
Last one week high and low of the scrip stood at Rs. 191.00 and Rs. 179.15 respectively. The current market cap of the company is Rs. 829.00 crore.
The promoters holding in the company stood at 47.93% while Institutions and Non-Institutions held 10.86% and 41.22% respectively.
Zensar Technologies, a leading provider of healthcare information technology solutions and BPO services, has unveiled a new tool called iCAn (ICD Converter & Analyzer). The iCAn tool is an integrated product which includes mapping, crosswalk, documentation updates and analysis to help healthcare providers facilitate the transition to ICD-10.
iCAn automatically converts ICD codes from ICD-9 to ICD-10 and vice versa. The tool has the capability to accurately convert ICD codes using GEMs and custom mapping rules. iCAn meets the mapping needs of the entire healthcare enterprise and can act as the single source of truth for code conversions.
The new iCAn tool is part of the company’s overall healthcare information technology offerings for both clinical and business applications that are designed to help providers deliver patient care in a connected, streamlined and a patient-centric environment. The company’s wide range of comprehensive solutions for all clinical and administrative systems allows healthcare providers to optimize workflow, improve efficiency, meet compliance mandates and enhance patient care.
Zensar Technologies is among the top 20 software services providers from India. Zensar is the world's first enterprise-wide SEI CMM Level 5 Company and was also later certified as a CMMI Level 5 Company with industry expertise that spans Retail, Manufacturing, Banking, Insurance, Utilities, Healthcare and Life Sciences.
| Company Name | CMP |
|---|---|
| TCS | 4168.05 |
| Infosys | 1922.05 |
| HCL Tech. | 1911.20 |
| Wipro | 305.15 |
| Tech Mahindra | 1685.20 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Limited to the first 10 users today!
Practical Stock Investing Hand Book
By - Raymond Moses
Founder of MoneyWorks4Me | Consultant | Trainer | Author | TEDx Speaker
Register & Get Instant Access!Don't miss out! First 10 users today get it FREE
With this 4 hrs Masterclass, you’ll be able to:
Download APP
